United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

Mass General Brigham has announced the successful completion of another gene-edited pig kidney transplant, the first of a ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

The second person ever has received a transplant with a genetically modified pig kidney.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

United Therapeutics could eventually use the genetically edited swine to grow organs for human transplant recipients. A ...